TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Thor Life Science Consulting AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
|
2,045
|
1,355 |
Financial expenses |
21
|
0
![]() |
0 |
Earnings before taxes |
-13
|
1,349
|
809 |
EBITDA |
-30
|
1,347
|
810 |
Total assets |
2,256
|
2,382
|
1,305 |
Current assets |
2,256
|
2,358
|
1,280 |
Current liabilities |
245
|
488
|
292 |
Equity capital |
1,980
|
1,863
|
1,013 |
- share capital |
51
|
47
|
49 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
87.8%
|
78.2%
|
77.6% |
Turnover per employee |
0
|
2,045
|
1,355 |
Profit as a percentage of turnover |
66.0%
|
59.7% | |
Return on assets (ROA) |
0.4%
|
56.6%
|
62.0% |
Current ratio |
920.8%
|
483.2%
|
438.4% |
Return on equity (ROE) |
-0.7%
|
72.4%
|
79.9% |
Change turnover |
-2,190
|
731
|
1,233 |
Change turnover % |
-100%
|
56%
|
1011% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.